These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

86 related articles for article (PubMed ID: 11211030)

  • 1. Antibiotic therapy and peritonitis.
    Crowley B
    Lancet; 2001 Feb; 357(9253):396. PubMed ID: 11211030
    [No Abstract]   [Full Text] [Related]  

  • 2. Post-operative peritonitis due to a KPC-producing
    Chatzopoulou M; Tsiakalou M
    Pan Afr Med J; 2018; 30():129. PubMed ID: 30374375
    [No Abstract]   [Full Text] [Related]  

  • 3. Spontaneous bacterial peritonitis due to carbapenemase-producing Klebsiella pneumoniae: the last therapeutic challenge.
    Piano S; Romano A; Rosi S; Gatta A; Angeli P
    Eur J Gastroenterol Hepatol; 2012 Oct; 24(10):1234-7. PubMed ID: 22713510
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Klebsiella pneumoniae peritonitis shortly after kidney transplantation.
    Ekmekci Y; Sengul S; Kutlay S; Azap A; Tuzuner A; Erbay B
    Transplant Proc; 2005 Jun; 37(5):2122-3. PubMed ID: 15964356
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Oral ciprofloxacin to treat bacterial peritonitis associated with peritoneal dialysis.
    Leblanc M
    Clin Nephrol; 1997 May; 47(5):350. PubMed ID: 9181286
    [No Abstract]   [Full Text] [Related]  

  • 6. Outcomes of transplantation using organs from a donor infected with Klebsiella pneumoniae carbapenemase (KPC)-producing K. pneumoniae.
    Ariza-Heredia EJ; Patel R; Blumberg EA; Walker RC; Lewis R; Evans J; Sankar A; Willliams MD; Rogers J; Milano C; Razonable RR
    Transpl Infect Dis; 2012 Jun; 14(3):229-36. PubMed ID: 22624726
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Antibiotic modulation in a clinically relevant model of chronic intraabdominal infection.
    Woods DR; Heffley S; Peyton JC; Cheadle WG
    Am Surg; 2006 Jul; 72(7):655-60. PubMed ID: 16875092
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Immunopotentiation in infectious disease, II. Effect of bestatin on experimental infection.
    Ormrod DJ; Clarke IA; Miller TE
    Chemioterapia; 1985 Aug; 4(4):324-8. PubMed ID: 3902258
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Failure of polymyxin B and fosfomycin combination to eradicate extensively antibiotic Klebsiella pneumoniae from the urine despite in-vitro activity.
    Arroyo JC; Allison-Ard C
    J S C Med Assoc; 2011; 107 Suppl():3-6. PubMed ID: 22057591
    [No Abstract]   [Full Text] [Related]  

  • 10. "Spontaneous" bacterial peritonitis: transfallopian route of infection confirmed.
    Brinson RR
    Gastroenterology; 1985 Nov; 89(5):1214-5. PubMed ID: 3899844
    [No Abstract]   [Full Text] [Related]  

  • 11. Antibiotic-loaded, silver core-embedded mesoporous silica nanovehicles as a synergistic antibacterial agent for the treatment of drug-resistant infections.
    Wang Y; Ding X; Chen Y; Guo M; Zhang Y; Guo X; Gu H
    Biomaterials; 2016 Sep; 101():207-16. PubMed ID: 27294538
    [TBL] [Abstract][Full Text] [Related]  

  • 12. [Severe Laryngotracheal Involvement in a Case of Rhinoscleroma Due to Klebsiella pneumoniae Subspecies ozaenae].
    Costa Climent MD; Marín Royo M; Sabater Vidal S
    Arch Bronconeumol; 2008 Dec; 44(12):692. PubMed ID: 19091241
    [No Abstract]   [Full Text] [Related]  

  • 13. Spontaneous bacterial peritonitis (SBP).
    Hemadeh G
    J Med Liban; 2001; 49(2):106-12. PubMed ID: 11910965
    [No Abstract]   [Full Text] [Related]  

  • 14. Carbapenem-sparing antibiotic regimens for infections caused by Klebsiella pneumoniae carbapenemase-producing K. pneumoniae in intensive care unit.
    Sbrana F; Malacarne P; Viaggi B; Costanzo S; Leonetti P; Leonildi A; Casini B; Tascini C; Menichetti F
    Clin Infect Dis; 2013 Mar; 56(5):697-700. PubMed ID: 23155147
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Endotoxemia induced by antibiotic therapy: a mechanism for adrenal corticosteroid protection in gram-negative sepsis.
    Johnston CA; Greisman SE
    Trans Assoc Am Physicians; 1984; 97():172-81. PubMed ID: 6398946
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Microbial tolerance in secondary peritonitis is dose dependent.
    Lenz AM; Turina M; Alard P; Gardner SA; Cheadle WG
    Cell Immunol; 2009; 258(1):98-106. PubMed ID: 19393606
    [TBL] [Abstract][Full Text] [Related]  

  • 17. [Aspects of the antimicrobial resistence profile in infections with Escherichia coli and Klebsiella pneumoniae in diabetic patients].
    Petrovici CG; Dorobăţ C; Matei M; Teodor A; Luca V; Miftode E
    Rev Med Chir Soc Med Nat Iasi; 2011; 115(3):769-75. PubMed ID: 22046785
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Dual intraventricular plus systemic antibiotic therapy for the treatment of Klebsiella pneumoniae carbapenemase-producing Klebsiella pneumoniae ventriculitis.
    Nevrekar S; Cunningham KC; Greathouse KM; Panos NG
    Ann Pharmacother; 2014 Feb; 48(2):274-8. PubMed ID: 24259634
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Efficacy of imipenem for the treatment of bacteremia due to an OXA-48-producing Klebsiella pneumoniae isolate.
    Maherault AC; Nordmann P; Therby A; Pangon B
    Clin Infect Dis; 2012 Feb; 54(4):577-8. PubMed ID: 22157173
    [No Abstract]   [Full Text] [Related]  

  • 20. Treatment of carbapenem-resistant Klebsiella pneumoniae: the state of the art.
    Petrosillo N; Giannella M; Lewis R; Viale P
    Expert Rev Anti Infect Ther; 2013 Feb; 11(2):159-77. PubMed ID: 23409822
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 5.